In these studies, more advanced stages of NAFLD associated with global hypomethylation and concomitant over-activation of a pro-fibrogenic gene programme, as exemplified at FGFR2 (75). Here, FGFR2 is linked to metabolic dysfunction-associated steatotic liver disease.